Marcello Silvestro

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Journal: Cephalalgia : an international journal of headache

Published: June 26, 2026

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience.

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience.

Journal: Toxins

Published: June 01, 2026

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 07, 2026

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Journal: Cephalalgia : an international journal of headache

Published: February 13, 2026

From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture.

From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture.

Journal: Neurobiology of disease

Published: February 09, 2026

The Relevance of Crystal Clear and Unclear Days to Evaluate Residual Interictal Burden in Patients With Migraine Treated With CGRP Monoclonal Antibodies.

The Relevance of Crystal Clear and Unclear Days to Evaluate Residual Interictal Burden in Patients With Migraine Treated With CGRP Monoclonal Antibodies.

Journal: European journal of neurology

Published: February 02, 2026

Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.

Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.

Journal: Frontiers in neuroscience

Published: November 30, 2025

Response to the Letter by Tfelt-Hansen and Hougaard "Some observed problems of the evidence presented for zolmitriptan nasal spray in the "Evidence-Based Recommendations of Pharmacological Treatment of Migraine Attacks".

Response to the Letter by Tfelt-Hansen and Hougaard "Some observed problems of the evidence presented for zolmitriptan nasal spray in the "Evidence-Based Recommendations of Pharmacological Treatment of Migraine Attacks".

Journal: Cephalalgia : an international journal of headache

Published: November 06, 2025

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies.

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies.

Journal: Headache

Published: September 09, 2025

Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Journal: Cephalalgia : an international journal of headache

Published: August 28, 2025

Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study).

Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study).

Journal: Therapeutic advances in neurological disorders

Published: June 25, 2025

Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study.

Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study.

Journal: Frontiers in neurology

Published: June 18, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026